Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.004 | 0.0691 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0342 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.066 | 0.066 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.004 | 0.0691 | 0.0691 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0045 | 0.0847 | 0.0847 |
Trypanosoma cruzi | agmatinase, putative | 0.0125 | 0.3305 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0045 | 0.0847 | 0.2562 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 0.066 | 0.0349 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.004 | 0.0691 | 0.5 |
Plasmodium falciparum | arginase | 0.0342 | 1 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0045 | 0.0847 | 0.0702 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0045 | 0.0847 | 0.0847 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.066 | 0.0512 |
Treponema pallidum | flavodoxin | 0.0017 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.066 | 0.066 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.066 | 0.066 |
Echinococcus multilocularis | arginase 2, mitochondrial | 0.0342 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0045 | 0.0847 | 0.0847 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0045 | 0.0847 | 0.0542 |
Trypanosoma cruzi | p450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Chlamydia trachomatis | sulfite reductase | 0.0028 | 0.0322 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0045 | 0.0847 | 0.0542 |
Leishmania major | agmatinase-like protein | 0.0125 | 0.3305 | 0.3305 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0847 | 1 |
Trichomonas vaginalis | Arginase, putative | 0.0342 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 0.066 | 0.0349 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0045 | 0.0847 | 0.2562 |
Trypanosoma cruzi | arginase, putative | 0.0125 | 0.3305 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0342 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0028 | 0.0322 | 0.3805 |
Trypanosoma brucei | agmatinase, putative | 0.0125 | 0.3305 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0045 | 0.0847 | 0.0542 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0022 | 0.0166 | 0.0011 |
Brugia malayi | flavodoxin family protein | 0.0045 | 0.0847 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0045 | 0.0847 | 0.0847 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0045 | 0.0847 | 0.5 |
Echinococcus granulosus | arginase 2 mitochondrial | 0.0342 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0022 | 0.0156 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0028 | 0.0322 | 0.0169 |
Trypanosoma cruzi | agmatinase, putative | 0.0125 | 0.3305 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 0.066 | 0.0512 |
Echinococcus multilocularis | 0.0342 | 1 | 1 | |
Brugia malayi | FAD binding domain containing protein | 0.0045 | 0.0847 | 1 |
Leishmania major | cytochrome P450 reductase, putative | 0.004 | 0.0691 | 0.0691 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0022 | 0.0156 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0045 | 0.0847 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0045 | 0.0847 | 0.2562 |
Leishmania major | arginase | 0.0342 | 1 | 1 |
Entamoeba histolytica | Arginase, putative | 0.0342 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0045 | 0.0847 | 0.0542 |
Schistosoma mansoni | arginase | 0.0342 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0028 | 0.0322 | 0.3805 |
Brugia malayi | hypothetical protein | 0.0039 | 0.066 | 0.7796 |
Plasmodium vivax | flavodoxin domain containing protein | 0.004 | 0.0691 | 0.0691 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0045 | 0.0847 | 0.0847 |
Plasmodium vivax | arginase, putative | 0.0342 | 1 | 1 |
Trypanosoma cruzi | arginase, putative | 0.0125 | 0.3305 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.066 | 0.066 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 17764148 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.